Andover, MA, United States of America

Jeffrey Scott Arnold

USPTO Granted Patents = 6 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey Scott Arnold

Introduction

Jeffrey Scott Arnold is a notable inventor based in Andover, MA (US). He has made significant contributions to the field of biopharmaceuticals, holding a total of 6 patents. His work focuses on innovative methods for drug delivery and targeting specific receptors in the treatment of various diseases.

Latest Patents

Arnold's latest patents include groundbreaking methods for attaching mannose-binding C-type lectin receptor targeting moieties to polymeric carbohydrate backbones using amide linkages. This method enhances the stability of compounds and reduces the loss of targeting moieties. Another significant patent involves the development of drug delivery vehicles that utilize nitrogenous bisphosphonate compounds coupled to a polymeric carbohydrate backbone via thiol-maleimide conjugation. These vehicles are designed to release therapeutic payloads when internalized into specific cells, such as tumor-associated macrophages, providing potential treatments for cancer and autoimmune diseases.

Career Highlights

Arnold is currently associated with Navidea Biopharmaceuticals, Inc., where he continues to innovate in the field of drug delivery systems. His work has been instrumental in advancing therapeutic strategies that target specific cellular receptors, thereby improving treatment efficacy.

Collaborations

Arnold collaborates with various professionals in the field, including his coworker David A Ralph, to further enhance the impact of his inventions.

Conclusion

Jeffrey Scott Arnold's contributions to biopharmaceuticals through his innovative patents and collaborative efforts highlight his role as a leading inventor in the industry. His work continues to pave the way for advancements in targeted drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…